Psilocybin and therapy for severe alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether a therapy that uses a psychedelic substance called psilocybin (a hallucinogen) can help people with severe alcohol problems. You would receive it in a supervised setting along with talk therapy, with the goal of helping you cut back or stop drinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old and speak English.
- You must have a confirmed severe alcohol use disorder (AUD).
- You must have completed detox from alcohol within the last 90 days.
- You must be willing to attend all study visits and therapy sessions at Brigham and Women's Hospital.
- You need to have a support person who can stay with you after the psilocybin sessions.
- You cannot have certain mental health conditions like schizophrenia or bipolar disorder, or have a close family member with them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.
This study tests whether psilocybin (a psychedelic compound) can help people with severe alcohol use disorder stay sober longer, especially if they also have depression. Participants receive guided psilocybin sessions alongside counseling to reduce the risk of returning to heavy drinking.
This trial tests two psychedelic-assisted therapies, psilocybin and ketamine, to see which works better for reducing heavy drinking in people with alcohol use disorder (AUD). You'll receive either drug along with counseling, and the study monitors safety closely.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This study tests whether psilocybin (a psychedelic compound) combined with talk therapy can help people who have both major depression and alcohol use disorder. The goal is to see if it can improve mood and reduce drinking.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.